Tags

Type your tag names separated by a space and hit enter

Anti-(apolipoprotein A-1) IgGs are associated with high levels of oxidized low-density lipoprotein in acute coronary syndrome.
Clin Sci (Lond) 2008; 115(1):25-33CS

Abstract

ApoA-1 (apolipoprotein A-1) is the main component of HDL (high-density lipoprotein) and stabilizes PON-1 (paraoxonase-1), which prevents lipid peroxidation and oxLDL (oxidized low-density lipoprotein) formation. Autoantibodies against apoA-1 [anti-(apoA-1) IgG] have been found in antiphospholipid syndrome and systemic lupus erythematosous, two diseases with an increased risk of thrombotic events, as well as in ACS (acute coronary syndrome). OxLDL levels are also elevated in these diseases. Whether anti-(apoA-1) IgGs exist in other prothrombotic conditions, such as APE (acute pulmonary embolism) and stroke, has not been studied and their potential association with oxLDL and PON-1 activity is not known. In the present study, we determined prospectively the prevalence of anti-(apoA-1) IgG in patients with ACS (n=127), APE (n=58) and stroke (n=34), and, when present, we tested their association with oxLDL levels. The prevalance of anti-(apoA-1) IgG was 11% in the ACS group, 2% in the control group and 0% in the APE and stroke groups. The ACS group had significantly higher median anti-(apoA-1) IgG titres than the other groups of patients. Patients with ACS positive for anti-(apoA-1) IgG had significantly higher median oxLDL values than those who tested negative (226.5 compared with 47.7 units/l; P<0.00001) and controls. The Spearman ranked test revealed a significant correlation between anti-(apoA-1) IgG titres and serum oxLDL levels (r=0.28, P<0.05). No association was found between PON-1 activity and oxLDL or anti-(apoA-1) IgG levels. In conclusion, anti-(apoA-1) IgG levels are positive in ACS, but not in stroke or APE. In ACS, their presence is associated with higher levels of oxLDL and is directly proportional to the serum concentration of oxLDL. These results emphasize the role of humoral autoimmunity as a mediator of inflammation and coronary atherogenesis.

Authors+Show Affiliations

Division of Immunology and Allergy, Department of Internal Medicine, University Hospital, Geneva, Switzerland.

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

18088236

Citation

Vuilleumier, Nicolas, et al. "Anti-(apolipoprotein A-1) IgGs Are Associated With High Levels of Oxidized Low-density Lipoprotein in Acute Coronary Syndrome." Clinical Science (London, England : 1979), vol. 115, no. 1, 2008, pp. 25-33.
Vuilleumier N, Charbonney E, Fontao L, et al. Anti-(apolipoprotein A-1) IgGs are associated with high levels of oxidized low-density lipoprotein in acute coronary syndrome. Clin Sci. 2008;115(1):25-33.
Vuilleumier, N., Charbonney, E., Fontao, L., Alvarez, M., Turck, N., Sanchez, J. C., ... Roux-Lombard, P. (2008). Anti-(apolipoprotein A-1) IgGs are associated with high levels of oxidized low-density lipoprotein in acute coronary syndrome. Clinical Science (London, England : 1979), 115(1), pp. 25-33.
Vuilleumier N, et al. Anti-(apolipoprotein A-1) IgGs Are Associated With High Levels of Oxidized Low-density Lipoprotein in Acute Coronary Syndrome. Clin Sci. 2008;115(1):25-33. PubMed PMID: 18088236.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Anti-(apolipoprotein A-1) IgGs are associated with high levels of oxidized low-density lipoprotein in acute coronary syndrome. AU - Vuilleumier,Nicolas, AU - Charbonney,Emmanuel, AU - Fontao,Lionel, AU - Alvarez,Montserrat, AU - Turck,Natacha, AU - Sanchez,Jean-Charles, AU - Burkhard,Pierre R, AU - Mensi,Noury, AU - Righini,Marc, AU - Reber,Guido, AU - James,Richard, AU - Mach,François, AU - Chevrolet,Jean-Claude, AU - Dayer,Jean-Michel, AU - Frostegard,Johan, AU - Roux-Lombard,Pascale, PY - 2007/12/20/pubmed PY - 2009/1/8/medline PY - 2007/12/20/entrez SP - 25 EP - 33 JF - Clinical science (London, England : 1979) JO - Clin. Sci. VL - 115 IS - 1 N2 - ApoA-1 (apolipoprotein A-1) is the main component of HDL (high-density lipoprotein) and stabilizes PON-1 (paraoxonase-1), which prevents lipid peroxidation and oxLDL (oxidized low-density lipoprotein) formation. Autoantibodies against apoA-1 [anti-(apoA-1) IgG] have been found in antiphospholipid syndrome and systemic lupus erythematosous, two diseases with an increased risk of thrombotic events, as well as in ACS (acute coronary syndrome). OxLDL levels are also elevated in these diseases. Whether anti-(apoA-1) IgGs exist in other prothrombotic conditions, such as APE (acute pulmonary embolism) and stroke, has not been studied and their potential association with oxLDL and PON-1 activity is not known. In the present study, we determined prospectively the prevalence of anti-(apoA-1) IgG in patients with ACS (n=127), APE (n=58) and stroke (n=34), and, when present, we tested their association with oxLDL levels. The prevalance of anti-(apoA-1) IgG was 11% in the ACS group, 2% in the control group and 0% in the APE and stroke groups. The ACS group had significantly higher median anti-(apoA-1) IgG titres than the other groups of patients. Patients with ACS positive for anti-(apoA-1) IgG had significantly higher median oxLDL values than those who tested negative (226.5 compared with 47.7 units/l; P<0.00001) and controls. The Spearman ranked test revealed a significant correlation between anti-(apoA-1) IgG titres and serum oxLDL levels (r=0.28, P<0.05). No association was found between PON-1 activity and oxLDL or anti-(apoA-1) IgG levels. In conclusion, anti-(apoA-1) IgG levels are positive in ACS, but not in stroke or APE. In ACS, their presence is associated with higher levels of oxLDL and is directly proportional to the serum concentration of oxLDL. These results emphasize the role of humoral autoimmunity as a mediator of inflammation and coronary atherogenesis. SN - 1470-8736 UR - https://www.unboundmedicine.com/medline/citation/18088236/Anti__apolipoprotein_A_1__IgGs_are_associated_with_high_levels_of_oxidized_low_density_lipoprotein_in_acute_coronary_syndrome_ L2 - http://clinsci.org/cgi/pmidlookup?view=long&amp;pmid=18088236 DB - PRIME DP - Unbound Medicine ER -